You searched for "Neuromod"

270 results found

Tinnitus treatment device from concept to commercialisation

Innovation in the field of healthcare is fraught with nearly insurmountable challenges. Bringing a novel product to the market requires a new (patentable) idea that can be reduced to practice, manufactured at scale, and can pass all regulatory barriers. In...

How effective and safe is audiologist-led screening of acoustic neuroma in patients with asymmetrical hearing loss and unilateral tinnitus?

About two out of 100 patients presenting with asymmetric hearing and unilateral tinnitus have acoustic neuroma. The traditional method in which these patients first attend a clinician and then undergo screening through an MRI, can be expensive and prolong the...

The British Acoustic Neuroma Association (BANA) Annual Conference 2025

The British Acoustic Neuroma Association (BANA) will host their Annual Conference this year in Ashover in the Peak District, this year focusing on members’ personal experiences. BANA (British Acoustic Neuroma Association) is a registered charity providing invaluable information and support to people with Acoustic Neuroma / Vestibular Schwannoma (ANVS) and their support networks.

Breakthrough tinnitus device Lenire available in three new clinics in Spain

Neuromod has announced that clinically proven tinnitus treatment device, Lenire, is now available in Malaga, Seville and Granada through partnership with medical technology distributor, TRUSBIN.

A cost reducing protocol for magnetic resonance imaging in patients suspected to have acoustic neuroma

Magnetic resonance imaging is the ‘gold standard’ for screening patients suspected to have an acoustic neuroma. However, inappropriate referrals for imaging are not helpful, especially with the growing need to reduce costs. In this study the authors compared two audit...

Controlled clinical trial results for FDA-approved tinnitus treatment device Lenire published in Nature Communications

Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial for the first and only FDA-approved bimodal tinnitus treatment device, Lenire.

UK clinics providing Lenire tinnitus treatment device double in latest expansion

Neuromod Devices, the medical device company that specialises in tinnitus treatment, has announced they are partnering with four UK clinics to expand the availability of Lenire®, the clinically proven tinnitus treatment device. Tinnitus, which is commonly known as “ringing in...

Vascular loops found on MRI IAM for tinnitus

This group from the Netherlands looks at the finding of vascular loops found on MRI IAMs requested for tinnitus. It is a common finding for all who request such imaging. This work adds to the body of evidence that such...

Subjective tinnitus – adding mutebutton™ to your tinnitus toolbox

Neurophysiologic tinnitus or subjective tinnitus is typically a sound or a number of sounds that originate from the auditory nervous system. They are unwanted sounds that do not exist in the external environment. They can be heard in one or...

Lenire as a clinical tool for treatment of tinnitus

Lenire offers a promising but varied solution for tinnitus relief. Peter Byrom shares insights on its effectiveness, challenges and patient outcomes. I have been involved in tinnitus support for at least 20 years, including a stint on the then British...

Small vestibular schwannomas (VS) – is waiting the right thing to do?

VS management can be surgical, by radiosurgery or watchful waiting. Middle fossa approach (MCF) can be implemented in small and some medium-size tumours, and has the potential to preserve hearing. The authors measured quality of life of VS patients who...

Persistent imbalance after traumatic brain injury is central in origin

Several residual symptoms, including dizziness and imbalance, can follow traumatic brain injury, no matter how mild. This study focused on the mechanisms, peripheral and central, underlying the complaint of persistent imbalance in patients with chronic mild traumatic brain injury (mTBI)....